Zuranolone provides a rapid response without chronic dosing: Response to correspondence by ten Doesschate et al

J Affect Disord. 2022 Mar 15:301:445-447. doi: 10.1016/j.jad.2022.01.059. Epub 2022 Jan 13.

Authors

Alix Arnaud¹, Vijayveer Bonthapally²

Affiliations

¹ Sage Therapeutics Inc., 215 First St, Cambridge, MA 02142, United States.
² Sage Therapeutics Inc., 215 First St, Cambridge, MA 02142, United States. Electronic address: [email protected].

PMID: 35032505
DOI: 10.1016/j.jad.2022.01.059

No abstract available

Keywords: Depression; Major depressive disorder; Mental health; Neuroactive steroid; Zuranolone.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Pregnanes*
Pyrazoles*

Substances

Pregnanes
Pyrazoles
zuranolone